Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why AbbVie Stock Is Tanking Today

TheMotleyFool

0 0

Shares of the Illinois-based drugmaker AbbVie (NYSE: ABBV) were down by a hefty 5% as of 2:32 p.m. ET Friday afternoon. As a result, the Dividend Aristocrat's market capitalization has slipped by a staggering $13.2 billion today.

Why are investors hitting the exits today? Ahead of the opening bell, AbbVie announced its 2022 second-quarter earnings. With biosimilar competition eroding the sales of its top-selling anti-inflammatory medication, Humira, in Europe, investors were hoping to see its aesthetics and cancer portfolios pick up the slack. Unfortunately, these two key franchises posted unusually weak financial results for the three-month period.

Image source: Getty Images.

Source Fool.com

Like: 0

ABBV

Share